Ellie Ivanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ellie Ivanova has a total of 161 co-authors. Here are the top co-authors by number of shared publications:
- Sergei B. Koralov
Department of Pathology, New York University Grossman School of Medicine, New York, USA
36 shared publications - Alberto M. Herrera
Infectious Diseases Division, Department of Medicine, Weill Cornell Medical College, New York, USA
21 shared publications - Thales Papagiannakopoulos
Department of Pathology, New York University Grossman School of Medicine, New York, USA
21 shared publications - Aristotelis Tsirigos
Department of Pathology, New York University Grossman School of Medicine, New York, USA
19 shared publications - Burcu Karadal-Ferrena
Department of Pathology, New York University Grossman School of Medicine
19 shared publications - Charles M. Rudin
Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
19 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Gating strategy for immune cells.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Gating strategy for immune cells.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S2 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Immune Analysis of Lkb1 mutant lung tumors by scRNA-seq.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S2 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Immune Analysis of Lkb1 mutant lung tumors by scRNA-seq.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Immune analysis of murine Lkb1 mutant lung tumors by flow cytometry.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Immune analysis of murine Lkb1 mutant lung tumors by flow cytometry.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Loss of function mutations in Lkb1 enhance tumorigenesis.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Loss of function mutations in Lkb1 enhance tumorigenesis.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Depletion of interstitial macrophages in Lkb1 mutant lung tumors after clodronate administration increases effector T cell function.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Depletion of interstitial macrophages in Lkb1 mutant lung tumors after clodronate administration increases effector T cell function.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S13 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
LIF neutralization eliminates a dedifferentiated stem-like tumor cell state.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S13 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
LIF neutralization eliminates a dedifferentiated stem-like tumor cell state.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Lkb1 mutant tumors transcriptionally upregulate the cytokine LIF.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Lkb1 mutant tumors transcriptionally upregulate the cytokine LIF.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Autocrine LIF signaling enhances tumorigenesis and inflammation.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Autocrine LIF signaling enhances tumorigenesis and inflammation.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S5 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Immune analysis of human LKB1 mutant lung tumors.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S5 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Immune analysis of human LKB1 mutant lung tumors.